For instance, the Jiangzhi granule ameliorated NASH in mice by activating intestinal FXR to increase secondary BAs and strengthen gut barrier integrity (Cao et al., 2022). Here, NR1H4 is linked to metabolic dysfunction-associated steatohepatitis.